Experiments for taxon Scleroderma citrinum (SCLERODERMATACEAE)

Experiments (19 results)

19 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
301600	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY: METHYL ESTER
301604	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY:
301599	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIVIRAL ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY: METHYL ESTER
827472	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)
827476	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)
301601	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY: METHYL ESTER
301594	X-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Scleroderma citrinum (SCLERODERMATACEAE)	LANOSTA-8-TRANS-23-DIEN-3-ONE,-22(S)-O-ACETYL-25-HYDROXY: 20(S):
301605	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY:
827473	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)
301598	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY: METHYL ESTER
827477	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)
443539	IDENTIFICATION OFQUANTITATIVE DATA REPORTED		Scleroderma citrinum (SCLERODERMATACEAE)	INDOLE-3-ACETIC ACID
827474	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)
301596	PHARMACOLOGY OF COMPOUND - IN VITRO	CYTOTOXIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	LANOSTA-8-TRANS-23-DIEN-3-ONE,-22(S)-O-ACETYL-25-HYDROXY: 20(S):
301602	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY:
301597	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIMYCOBACTERIAL ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	LANOSTA-8-TRANS-23-DIEN-3-ONE,-22(S)-O-ACETYL-25-HYDROXY: 20(S):
827475	PHARMACOLOGY OF EXTRACT - IN VITROCARCINOGENIC DATA (MARKER CODE)	MUTAGENIC ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)
301603	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIVIRAL ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	VULPINIC ACID,4-4'-DIMETHOXY:
301595	PHARMACOLOGY OF COMPOUND - IN VITRO	ANTIVIRAL ACTIVITY	Scleroderma citrinum (SCLERODERMATACEAE)	LANOSTA-8-TRANS-23-DIEN-3-ONE,-22(S)-O-ACETYL-25-HYDROXY: 20(S):